Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2010
04/29/2010US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
04/29/2010US20100105868 Method for detecting neuroblastoma
04/29/2010US20100105769 pharmaceutical composition containing daurinol for the prevention and treatment of cancers
04/29/2010US20100105760 Treatment of Apolipoprotein-A1 Related Diseases by Inhibition of Natural Antisense Transcript to Apolipoprotein-A1
04/29/2010US20100105745 Suppression of cancer and method for evaluating anticancer agent based on the effect of inhibiting gsk3 beta
04/29/2010US20100105698 Therapeutic Methods and Compounds
04/29/2010US20100105653 Pyrrolopyrimidine compounds and their uses
04/29/2010US20100105645 Inhibition of ppar gamma expression by specific osteogenic oxysterols
04/29/2010US20100105623 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs
04/29/2010US20100105620 Polypeptides that bind Trail-R1 and Trail-R2
04/29/2010US20100105618 Non-Natural Recombinant Gelatins with Enhanced Functionality
04/29/2010US20100105612 Agent containing fused protein of soluble rankl with epitope tag
04/29/2010US20100105599 Subtilisin variants
04/29/2010US20100105574 Cancer stem cells and uses thereof
04/29/2010US20100105141 Sulfonylurea-Responsive Repressor Proteins
04/29/2010US20100105140 Plaice dna transposon system
04/29/2010US20100105138 Premounted fluid conveyance assembly for cell expansion system and method of use associated therewith
04/29/2010US20100105137 Method for induction/differentiation into photoreceptor cell
04/29/2010US20100105136 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
04/29/2010US20100105135 Porous membrane device that promotes the differentiation of monocytes into dendritic cells
04/29/2010US20100105134 Nucleic acid compounds for inhibiting gene expression and uses thereof
04/29/2010US20100105133 Somatic Cells for Use in Cell Therapy
04/29/2010US20100105132 Human Mesenchymal stem cells and preparation thereof
04/29/2010US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
04/29/2010US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
04/29/2010US20100105108 Method and device for producing vaccine
04/29/2010US20100105106 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity
04/29/2010US20100105100 Multipotent/pluripotent cells and methods
04/29/2010US20100105090 Secreted luciferase mluc7 and use thereof
04/29/2010US20100105077 Means for Detection and Purification of CD8+ T Lymphocyte Populations Specific to Peptides Presented in the Context of HLA
04/29/2010US20100105073 Method for the production of antibodies
04/29/2010US20100105068 Hybridomas producing antibodies against non functional p2x7 receptor
04/29/2010US20100105051 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
04/29/2010US20100105043 Methods for modulating embryonic stem cell differentiation
04/29/2010US20100105021 Stabilisation of biological cell markers
04/29/2010US20100104658 Graft prosthesis, materials and methods
04/29/2010US20100104652 Use of advanced nanomaterials for increasing sepecific cell functions
04/29/2010US20100104600 Methods and Compositions for Increasing Tissue Tropism of Recombinant Adenoviral Vectors
04/29/2010US20100104597 N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
04/29/2010US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
04/29/2010US20100104587 Methods of modulating the negative chemotaxis of immune cells
04/29/2010US20100104586 Treatment of Carcinomas with a Combination of EGF-Pathway and Telomerase Inhibitors
04/29/2010US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization;
04/29/2010US20100104574 Frizzled-Binding Agents and Uses Thereof
04/29/2010US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
04/29/2010US20100104568 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
04/29/2010US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
04/29/2010US20100104560 Botulinum neurotoxin e receptors and uses thereof
04/29/2010US20100104559 Us cip-compositions and methods for modulating responses mediated or associated with btla activity
04/29/2010US20100104556 Epitope-tag for surface-expressed proteins and uses thereof
04/29/2010US20100104555 HCV neutralizing epitopes
04/29/2010US20100104544 Selective cell therapy for the treatment of renal failure
04/29/2010US20100104543 Cellular compositions and methods of making and using them
04/29/2010US20100104536 P38 inhibitors
04/29/2010US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery
04/29/2010US20100104531 Homogeneous preparations of il-28 and il-29
04/29/2010US20100104530 Anti-vpac1 antibodies and their uses
04/29/2010US20100104529 TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha
04/29/2010US20100104510 Selenocysteine mediated hybrid antibody molecules
04/29/2010US20100104508 Human antibodies that bind cxcr4 and uses thereof
04/29/2010US20100104507 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
04/29/2010CA2744100A1 Cell transplantation
04/29/2010CA2741493A1 Cell culture kit, screening method, and method of manufacturing cell culture kit
04/29/2010CA2741420A1 Amniotic fluid cells and uses thereof
04/29/2010CA2741336A1 Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions
04/29/2010CA2741090A1 Pluripotent stem cells obtained by non-viral reprogramming
04/29/2010CA2740241A1 Prostate stem cells and uses thereof
04/29/2010CA2740138A1 Methods for producing antibodies from plasma cells
04/29/2010CA2739801A1 Systems, apparatuses and methods for cultivating microorganisms and mitigation of gases
04/28/2010EP2180057A1 Vector system
04/28/2010EP2180046A1 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms
04/28/2010EP2180045A1 Novel protein highly producing recombinant animal cell, method for preparing the same and method for mass-producing protein using the same
04/28/2010EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity
04/28/2010EP2180043A1 Method for the differentiation of human adult stem cells into insulin-secreting cells
04/28/2010EP2180042A1 Methods and device to constrain multicellular arrangements in stable, stationary and reproducible spatial configuration
04/28/2010EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof
04/28/2010EP2180035A1 Alpha-amylase mutants with altered properties
04/28/2010EP2180007A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
04/28/2010EP2179738A2 Use of mesenchymal stem cells for treating osteoporosis
04/28/2010EP2179292A1 Metabolomic profiling of prostate cancer
04/28/2010EP2179034A1 A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells
04/28/2010EP2179033A1 Methods for promoting stem cell proliferation and survival
04/28/2010EP2179032A1 Method for preparing cells for engraftment
04/28/2010EP2179030A1 Human disc tissue
04/28/2010EP2179029A1 Method and device for forming biologic cell aggregates
04/28/2010EP2178920A1 An anti-cancer cytotoxic monoclonal antibody
04/28/2010EP2178919A1 An anti-cancer cytotoxic monoclonal antibody
04/28/2010EP2178918A1 An anti-cancer cytotoxic monoclonal antibody
04/28/2010EP2178550A2 Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof
04/28/2010EP2178544A1 Method and substance for promoting plant growth
04/28/2010EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
04/28/2010EP1641828B1 Anti-hgf-r antibodies and their use
04/28/2010EP1427828B1 Random integration of a polynucleotide after in vivo linearization
04/28/2010EP1356067B1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
04/28/2010EP1346036B1 Helper virus-free herpes virus amplicon particles and uses thereof
04/28/2010EP1297107B1 Intervertebral disc
04/28/2010EP1259606B1 Compositions useful for regulating parkin gene activity
04/28/2010CN1820020B SARS-coronavirus virus-like particles and methods of use
04/28/2010CN1813066B Novel beta-actin and rps21 promoters and uses thereof
04/28/2010CN1798832B Cultured cell construct containing spheroids of cultured animal cells and utilization thereof
1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 1827